|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.36 JOD | -1.45% |
|
0.00% | -4.90% |
Philadelphia Pharmaceuticals Company reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was JOD 5.97 million compared to JOD 5.97 million a year ago. Net income was JOD 0.542954 million compared to JOD 0.45107 million a year ago.
Basic earnings per share from continuing operations was JOD 0.072 compared to JOD 0.06 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.90% | 14.39M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B |
PHILADELPHIA PHARMACEUTICALS COMPANY 
